SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FRUTTAROLO, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.651
AS - Asia 2.623
EU - Europa 2.220
SA - Sud America 372
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 9.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.534
SG - Singapore 934
DE - Germania 930
CN - Cina 724
UA - Ucraina 285
BR - Brasile 282
VN - Vietnam 246
RU - Federazione Russa 240
HK - Hong Kong 222
TR - Turchia 210
GB - Regno Unito 205
FI - Finlandia 128
SE - Svezia 112
FR - Francia 106
IT - Italia 101
CA - Canada 62
IN - India 54
JP - Giappone 45
MX - Messico 44
AR - Argentina 43
BD - Bangladesh 38
ZA - Sudafrica 26
PL - Polonia 24
PK - Pakistan 23
ID - Indonesia 19
IQ - Iraq 18
BE - Belgio 15
MA - Marocco 14
CO - Colombia 13
SA - Arabia Saudita 13
ES - Italia 12
NL - Olanda 11
LT - Lituania 10
SK - Slovacchia (Repubblica Slovacca) 10
TW - Taiwan 9
IL - Israele 8
KR - Corea 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
EG - Egitto 7
KE - Kenya 6
MY - Malesia 6
PH - Filippine 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CL - Cile 5
EC - Ecuador 5
IR - Iran 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
PE - Perù 4
PY - Paraguay 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
IE - Irlanda 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
TN - Tunisia 3
AO - Angola 2
AT - Austria 2
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
KW - Kuwait 2
KZ - Kazakistan 2
NP - Nepal 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
DJ - Gibuti 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
ZW - Zimbabwe 1
Totale 9.937
Salva come PNG Salva come JPEG
Città #
Singapore 669
Woodbridge 434
Ashburn 424
San Jose 347
Fairfield 322
Jacksonville 281
Ann Arbor 271
Santa Clara 245
Beijing 242
Houston 235
Hong Kong 209
Chandler 206
Wilmington 157
Seattle 132
Dallas 101
Cambridge 84
Izmir 81
Nanjing 80
Los Angeles 77
Ho Chi Minh City 75
Munich 74
Boardman 64
Princeton 61
Bremen 55
New York 53
Hanoi 52
Helsinki 47
Lauterbourg 44
Tokyo 44
San Diego 39
Hefei 37
Shanghai 37
São Paulo 34
Falkenstein 32
London 27
Mexico City 26
Milan 26
Nanchang 25
Montreal 24
Turku 24
Frankfurt am Main 23
Changsha 22
San Mateo 22
Shenyang 22
Denver 19
Orem 18
Tianjin 18
Atlanta 17
Falls Church 16
Toronto 16
Brussels 15
Chennai 15
Da Nang 15
Johannesburg 15
Philadelphia 15
Phoenix 15
Warsaw 15
Brooklyn 14
Jiaxing 14
Haiphong 13
Moscow 13
Hebei 12
Kunming 12
Ankara 11
Chicago 11
Manchester 10
Rio de Janeiro 10
Auburn Hills 9
Baghdad 9
Brasília 9
Bratislava 9
Orange 9
San Francisco 9
Zhengzhou 9
Indiana 8
Jinan 8
Memphis 8
Mountain View 8
Stockholm 8
Bexley 7
Biên Hòa 7
Jeddah 7
Mumbai 7
The Dalles 7
Wroclaw 7
Boston 6
Espoo 6
Guangzhou 6
Roubaix 6
Taunsa 6
Bến Tre 5
Campinas 5
Charlotte 5
Columbus 5
Curitiba 5
Dearborn 5
Karachi 5
Medellín 5
Nuremberg 5
Ottawa 5
Totale 6.140
Salva come PNG Salva come JPEG
Nome #
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 264
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 263
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 250
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 242
DNA minor groove binders as potential antitumor and antimicrobial agents 241
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 240
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 240
Allosteric enhancers for A(1) adenosine receptor 238
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 229
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 225
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 224
Hybrid molecules between distamycin A and active moieties of antitumor agents 223
Hybrid molecules based on distamycin A as potential antitumor agents 219
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 216
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 213
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 212
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 210
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 209
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 209
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 209
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 203
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 198
Recent developments in the field of adenosine receptor ligands. 197
Recent improvements in the development of A2B adenosine receptor agonists 196
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 192
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 190
New strategies for the synthesis of A(3) adenosine receptor antagonists 186
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 185
Recent improvements in the development of A2B adenosine receptor agonists 181
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 179
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 176
Preparation of O-substituted-dibenzyl (thio)urea derivatives as TRPV1 receptor antagonists. 176
O-SUBSTITUTED-DIBENZYL UREA-DERIVATIVES AS TRPV1 RECEPTOR ANTAGONISTS 175
Preparation of O-substituted-dibenzyl urea derivatives as TRPV1 receptor antagonists. 173
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 171
Preparation of isoquinolinyl cyclohexenylacrylamides as transient receptor potential vanilloid 1 (TRPV1) receptor antagonists 167
Recent improvements in the field of A(3) adenosine receptor ligands 166
Preparation of N-aryl biarylcarboxamides as vanilloid-1 receptor modulators. 165
Recent developments in the field of adenosine receptor ligands 164
Synthesis of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines and related heterocycles 162
Ligands for A(2B) adenosine receptor subtype 155
New pyrrolo [2,1-f] purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione derivates as potent and selective human A3 adenosine receptor antagonists 155
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 149
Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models 141
Recent developments in the field of A2B and A3 adenosine receptors antagonists 137
DNA minor-groove binders. Design, synthesis, and biological evaluation of ligands structurally related to CC-1065, distamycin, and anthramycin 124
null 120
Synthesis and biological evaluation of new 8-heterocyclic xanthine derivative as highly potent and selective human A2B adenosine receptor antagonist 111
null 110
Synthesis and biological evaluation of 2-amino-3-(3 ',4 ',5 '-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents 110
null 104
null 82
null 73
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: A possible template for adenosine receptor subtypes? 72
Recent developments in the field of A(3) adenosine receptor antagonists 72
Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]-9H-purin-9-yl]-N-ethyl-be ta-D-ribofuranuronamide derivatives as useful templates for the development of A(2B) adenosine receptor agonists 64
Totale 9.957
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/2022575 12 69 42 26 41 26 21 21 16 36 55 210
2022/2023545 53 6 10 70 144 86 6 43 82 3 26 16
2023/2024255 29 33 13 4 12 18 25 28 6 2 5 80
2024/20251.279 20 47 98 56 154 186 17 58 140 119 198 186
2025/20263.460 414 150 270 466 514 275 417 168 254 397 112 23
Totale 9.957